Castlight Health Inc. (NYSE:CSLT) held one of the most bizarre IPO's of recent memory on 3/14/2014 selling 11,100,000 shares of B Class stock at $16/share, which was above their $13-$15 initial projected range. Goldman Sachs and Morgan Stanley were the main underwriters handing the IPO.
Although on the surface nothing about the IPO seems unusual it becomes borderline bizarre when considering that the $16 pricing gave CSLT, a company who at the time had 2013 revenues of $13 million, net losses of $62 million, and an accumulated deficit of $131.2 million, a $1.5 billion valuation. Yes, billion. Had this valuation stood the company would have been valued at over 100x revenues, a statistic that I have come to...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|